Can High-Flow oxygen make it easier to breathe without a ventilator?

NCT ID NCT07724392

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 24, 2026 · Last updated Jul 24, 2026

Summary

This study compares three methods of supporting breathing during a spontaneous breathing trial — the test used to see if a patient can be safely taken off a ventilator. The methods are a standard T-piece, pressure support ventilation, and high-flow humidified oxygen. The goal is to measure how much energy patients expend to breathe with each method. The trial enrolls 30 adults in the ICU who have been on a ventilator for more than 48 hours and are at high risk of extubation failure.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
high-flow humidified oxygen delivered via a device normally used for tracheostomies
What this could lead to
If high-flow oxygen reduces the work of breathing during weaning, it could lead to a better method for deciding when to remove the breathing tube, potentially reducing complications.
What could go wrong
This is a small, early physiological study in 30 people, not a large trial. It measures breathing effort, not patient outcomes, so even positive results may not translate to real-world benefits.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 30 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Jan 2027

An estimate. Start dates often move.

Expected to finish

Jan 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adult patient, of legal age * On invasive mechanical ventilation for more than 48 hours * With at least one criterion indicating a high risk of extubation failure: * Age \> 65 years * Chronic respiratory disease * Chronic cardiac disease * Capable of undergoing a mechanical ventilation weaning test ("weaning criterion"): * Respiratory rate \< 35 bpm * Adequate oxygenation: * SpO₂ ≥ 90% with FiO₂ ≤ 40% and PEEP ≤ 8 cm H₂O * Or PaO₂/FiO₂ ≥ 150 with PEEP ≤ 8 cm H₂O * Effective cough * Patient is alert (RASS score -2 to +1), without sedation * Hemodynamically stable or on the minimum effective dose * Patient has an invasive arterial pressure catheter for arterial blood sampling * Informed consent signed by a family member * Patient is enrolled in or eligible for a social security program Exclusion Criteria: * Resuscitation-associated neuromyopathy * History of neuromuscular disease * Admission for a neurological condition * Subjects currently excluded from another study, * Persons referred to in Articles L1121-5 through L1121-8 of the CSP (corresponding to all protected persons: pregnant women, women in labor, breastfeeding mothers, persons deprived of liberty by judicial or administrative decision, persons receiving psychiatric care pursuant to Articles L. 3212-1 and L. 3213-1 who are not covered by the provisions of Article L. 1121-8, persons admitted to a health or social care facility for purposes other than research, minors, and persons subject to a legal protection order or unable to give informed consent). * Staff members who report to the principal investigator

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Spontaneous breathing trial in icu are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The official record

    The full official record for this study. This one lists no contact details, but it is the first place any would appear.

    Open the record ↗

  2. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

More trials for these conditions

Other studies related to the condition(s) this trial covers.